Pulse Biosciences Welcomes New Talent with Stock Options

Pulse Biosciences, a company known for its unique nPulse™ technology, recently made a move to attract new talent. They gave stock options to three new employees. These options let them buy up to 13, 450 shares of the company's stock. The options have an exercise price of $13. 58 per share. This price matches the stock's value on November 18, 2025. The options will vest over four years, with a quarter vesting each year. This means the employees must stay with the company to get the full benefit. The company's Compensation Committee approved these awards. They did this to encourage the new employees to join. This is allowed under Nasdaq Listing Rule 5635(c)(4). The awards are part of the 2017 Inducement Equity Incentive Plan. Pulse Biosciences is all about innovation in health care. Their nPulse™ technology uses nanosecond pulses of electrical energy. It can clear cells without harming nearby tissue. The company is exploring uses for this technology. One area is treating atrial fibrillation. They also see potential in other markets. The company has several trademarks. These include Pulse Biosciences, nPulse, Vybrance, and CellFX. These are registered in the United States and other countries.